The Justice Department has disputed this study, but its own caginess about its classification system has not helped its cause.

ECONOMIST: A mixed inheritance for America's next attorney-general

Lyrica, a new medicine for neuropathic pain, has not been launched because the Drug Enforcement Agency still has to make a decision about its classification for the drug.

FORBES: Pfizer's Tough Transition